Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jacques Grosset
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Disorders
Procedures
Physiology
Anatomy
Sign-in to see full Profile
Network (preview)
42
Truffot-Pernot, Chantal
36
Ji, Baohong
24
Nuermberger, Eric
22
Jarlier, Vincent
20
Bishai, William
18
Lounis, Nacer
15
Perani, Evelyne
15
Tyagi, Sandeep
10
Dautzenberg, Bertrand
9
Perronne, Christian
9
Rosenthal, Ian
8
Cambau, Emmanuelle
7
Vernon, Andrew
6
Sougakoff, Wladimir
6
Yoshimatsu, Tetsuyuki
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jacques Grosset (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Williams Kathy N; Brickner Steven J; Stover Charles K; Zhu Tong; Ogden Adam; Tasneen Rokeya; Tyagi Sandeep; Grosset Jacques H; Nuermberger Eric L
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
American journal of respiratory and critical care medicine 2009;180(4):371-6.
-
2009: Dorman Susan E; Johnson John L; Goldberg Stefan; Muzanye Grace; Padayatchi Nesri; Bozeman Lorna; Heilig Charles M; Bernardo John; Choudhri Shurjeel; Grosset Jacques H; Guy Elizabeth; Guyadeen Priya; Leus Maria Corazon; Maltas Gina; Menzies Dick; Nuermberger Eric L; Villarino Margarita; Vernon Andrew; Chaisson Richard E;
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
American journal of respiratory and critical care medicine 2009;180(3):273-80.
-
2009: Makarov Vadim; Manina Giulia; Mikusova Katarina; Möllmann Ute; Ryabova Olga; Saint-Joanis Brigitte; Dhar Neeraj; Pasca Maria Rosalia; Buroni Silvia; Lucarelli Anna Paola; Milano Anna; De Rossi Edda; Belanova Martina; Bobovska Adela; Dianiskova Petronela; Kordulakova Jana; Sala Claudia; Fullam Elizabeth; Schneider Patricia; McKinney John D; Brodin Priscille; Christophe Thierry; Waddell Simon; Butcher Philip; Albrethsen Jakob; Rosenkrands Ida; Brosch Roland; Nandi Vrinda; Bharath Sowmya; Gaonkar Sheshagiri; Shandil Radha K; Balasubramanian Venkataraman; Balganesh Tanjore; Tyagi Sandeep; Grosset Jacques; Riccardi Giovanna; Cole Stewart T
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Science (New York, N.Y.) 2009;324(5928):801-4.
-
2009: Williams K N; Stover C K; Zhu T; Tasneen R; Tyagi S; Grosset J H; Nuermberger E
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Antimicrobial agents and chemotherapy 2009;53(4):1314-9.
-
2009: Converse Paul J; Karakousis Petros C; Klinkenberg Lee G; Kesavan Anup K; Ly Lan H; Allen Shannon Sedberry; Grosset Jacques H; Jain Sanjay K; Lamichhane Gyanu; Manabe Yukari C; McMurray David N; Nuermberger Eric L; Bishai William R
Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.
Infection and immunity 2009;77(3):1230-7.
-
2008: Be Nicholas A; Lamichhane Gyanu; Grosset Jacques; Tyagi Sandeep; Cheng Qi-Jian; Kim Kwang Sik; Bishai William R; Jain Sanjay K
Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system.
The Journal of infectious diseases 2008;198(10):1520-8.
-
2008: Rosenthal Ian M; Zhang Ming; Almeida Deepak; Grosset Jacques H; Nuermberger Eric L
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
American journal of respiratory and critical care medicine 2008;178(9):989-93.
-
2008: Tasneen Rokeya; Tyagi Sandeep; Williams Kathy; Grosset Jacques; Nuermberger Eric
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(10):3664-8.
-
2008: Nuermberger Eric; Tyagi Sandeep; Tasneen Rokeya; Williams Kathy N; Almeida Deepak; Rosenthal Ian; Grosset Jacques H
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(4):1522-4.
-
2007: Rosenthal Ian M; Zhang Ming; Williams Kathy N; Peloquin Charles A; Tyagi Sandeep; Vernon Andrew A; Bishai William R; Chaisson Richard E; Grosset Jacques H; Nuermberger Eric L
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
PLoS medicine 2007;4(12):e344.
-
2007: Almeida Deepak; Nuermberger Eric; Tyagi Sandeep; Bishai William R; Grosset Jacques
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2007;51(12):4261-6.
-
2007: Chauty Annick; Ardant Marie-Françoise; Adeye Ambroise; Euverte Hélène; Guédénon Augustin; Johnson Christian; Aubry Jacques; Nuermberger Eric; Grosset Jacques
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Antimicrobial agents and chemotherapy 2007;51(11):4029-35.
-
2007: Jain Sanjay K; Hernandez-Abanto S Moises; Cheng Qi-Jian; Singh Prabhpreet; Ly Lan H; Klinkenberg Lee G; Morrison Norman E; Converse Paul J; Nuermberger Eric; Grosset Jacques; McMurray David N; Karakousis Petros C; Lamichhane Gyanu; Bishai William R
Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice.
The Journal of infectious diseases 2007;195(11):1634-42.
-
2007: Davies G R; Pym A S; Mitchison D A; Nuermberger Eric L; Grosset Jacques H
Evaluation of new antituberculosis drugs in mouse models.
Antimicrobial agents and chemotherapy 2007;51(1):403; author reply 403-4.
-
2006: Nuermberger Eric; Rosenthal Ian; Tyagi Sandeep; Williams Kathy N; Almeida Deepak; Peloquin Charles A; Bishai William R; Grosset Jacques H
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2006;50(8):2621-5.
-
2006: Rosenthal Ian M; Williams Kathy; Tyagi Sandeep; Peloquin Charles A; Vernon Andrew A; Bishai William R; Grosset Jacques H; Nuermberger Eric L
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
American journal of respiratory and critical care medicine 2006;174(1):94-101.
-
2005: Maugein J; Dailloux M; Carbonnelle B; Vincent V; Grosset J;
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;26(6):1092-6.
-
2005: Nuermberger Eric; Tyagi Sandeep; Williams Kathy N; Rosenthal Ian; Bishai William R; Grosset Jacques H
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
American journal of respiratory and critical care medicine 2005;172(11):1452-6.
-
2005: Rosenthal Ian M; Williams Kathy; Tyagi Sandeep; Vernon Andrew A; Peloquin Charles A; Bishai William R; Grosset Jacques H; Nuermberger Eric L
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.
American journal of respiratory and critical care medicine 2005;172(11):1457-62.
-
2005: Ginsburg Amy Sarah; Sun Ronggai; Calamita Heather; Scott Cherise P; Bishai William R; Grosset Jacques H
Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.
Antimicrobial agents and chemotherapy 2005;49(9):3977-9.
-
2005: Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu G K; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.
Antimicrobial agents and chemotherapy 2005;49(8):3182-6.
-
2005: Tyagi Sandeep; Nuermberger E; Yoshimatsu T; Williams K; Rosenthal I; Lounis N; Bishai W; Grosset J
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2005;49(6):2289-93.
-
2005: Ginsburg Amy Sarah; Lee Jin; Woolwine Samuel C; Grosset Jacques H; Hamzeh Fayez M; Bishai William R
Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.
Antimicrobial agents and chemotherapy 2005;49(2):853-6.
-
2005: Casal M; Vaquero M; Rinder H; Tortoli E; Grosset J; Rüsch-Gerdes S; Gutiérrez J; Jarlier V
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries.
Microbial drug resistance (Larchmont, N.Y.) 2005;11(1):62-7.
-
2004: Nuermberger Eric L; Yoshimatsu Tetsuyuki; Tyagi Sandeep; Williams Kathy; Rosenthal Ian; O'Brien Richard J; Vernon Andrew A; Chaisson Richard E; Bishai William R; Grosset Jacques H
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;170(10):1131-4.
-
2004: Karakousis Petros C; Yoshimatsu Tetsuyuki; Lamichhane Gyanu; Woolwine Samuel C; Nuermberger Eric L; Grosset Jacques; Bishai William R
Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.
The Journal of experimental medicine 2004;200(5):647-57.
-
2004: Nuermberger Eric; Bishai William R; Grosset Jacques H
Latent tuberculosis infection.
Seminars in respiratory and critical care medicine 2004;25(3):317-36.
-
2004: Nuermberger E; Grosset J
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(4):243-55.
-
2004: Nuermberger E L; Yoshimatsu T; Tyagi S; Bishai W R; Grosset J H
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.
Infection and immunity 2004;72(2):1065-71.
-
2004: Nuermberger Eric L; Yoshimatsu Tetsuyuki; Tyagi Sandeep; O'Brien Richard J; Vernon Andrew N; Chaisson Richard E; Bishai William R; Grosset Jacques H
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;169(3):421-6.
-
2003: Quy H T W; Lan N T N; Borgdorff M W; Grosset J; Linh P D; Tung L B; van Soolingen D; Raviglione M; Cô N V; Broekmans J
Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(7):631-6.
-
2003: Ginsburg Amy Sarah; Grosset Jacques H; Bishai William R
Fluoroquinolones, tuberculosis, and resistance.
The Lancet infectious diseases 2003;3(7):432-42.
-
2003: Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert R J
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(6):575-9.
-
2003: Lamichhane Gyanu; Zignol Matteo; Blades Natalie J; Geiman Deborah E; Dougherty Annette; Grosset Jacques; Broman Karl W; Bishai William R
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(12):7213-8.
-
2003: Emmanuelli X; Grosset J
[Tuberculosis and poverty]
Revue des maladies respiratoires 2003;20(2 Pt 1):169-71.
-
2003: Grosset Jacques
Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.
Antimicrobial agents and chemotherapy 2003;47(3):833-6.
-
2002: Dega Herve; Bentoucha Abdelhalim; Robert Jerome; Jarlier Vincent; Grosset Jacques
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Antimicrobial agents and chemotherapy 2002;46(10):3193-6.
-
2002: Yoshimatsu Tetsuyuki; Nuermberger Eric; Tyagi Sandeep; Chaisson Richard; Bishai William; Grosset Jacques
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.
Antimicrobial agents and chemotherapy 2002;46(6):1875-9.
-
2002: Grosset Jacques; Zunic Laurence; Morcrette Christophe
[World epidemiology of tuberculosis and resistance against anti-tuberculosis drugs]
Annales de médecine interne 2002;153(2):107-12.
-
2001: Honoré N; Roche P W; Grosset J H; Cole S T
A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae.
Leprosy review 2001;72(4):441-8.
-
2001: Grosset J H; Cole S T
Genomics and the chemotherapy of leprosy.
Leprosy review 2001;72(4):429-40.
-
2001: Lounis N; Bentoucha A; Truffot-Pernot C; Ji B; O'Brien R J; Vernon A; Roscigno G; Grosset J
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
Antimicrobial agents and chemotherapy 2001;45(12):3482-6.
-
2001: Lounis N; Truffot-Pernot C; Bentoucha A; Robert J; Ji B; Grosset J
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.
Antimicrobial agents and chemotherapy 2001;45(11):3229-30.
-
2001: Bentoucha A; Robert J; Dega H; Lounis N; Jarlier V; Grosset J
Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.
Antimicrobial agents and chemotherapy 2001;45(11):3109-12.
-
2001: Astagneau P; Desplaces N; Vincent V; Chicheportiche V; Botherel A; Maugat S; Lebascle K; Léonard P; Desenclos J; Grosset J; Ziza J; Brücker G
Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak.
Lancet 2001;358(9283):747-51.
-
2001: Grosset J H
Newer drugs in leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 2001;69(2 Suppl):S14-8.
-
2001: Boelaert J R; Appelberg R; Gomes M S; Blasi E; Mazzolla R; Grosset J; Lounis N; Soteriadou K; Thiakaki M; Taramelli D; Tognazioli C
Experimental results on chloroquine and AIDS-related opportunistic infections.
Journal of acquired immune deficiency syndromes (1999) 2001;26(3):300-1.
-
2001: Lounis N; Truffot-Pernot C; Grosset J; Gordeuk V R; Boelaert J R
Iron and Mycobacterium tuberculosis infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;20(3):123-6.
-
2000: Cambau E; Truffot-Pernot C; Boulahbal F; Wichlacz C; Grosset J; Jarlier V
Mycobacterial growth indicator tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(12):938-42.
-
2000: Ji B; Grosset J
Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
Leprosy review 2000;71 Suppl():S81-7.
-
2000: Nguyen L N; Cartel J L; Grosset J H
Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years.
Leprosy review 2000;71 Suppl():S33-5; discussion S35-6.
-
2000: Grosset J
The new challenges for chemotherapy research.
Leprosy review 2000;71 Suppl():S100-4.
-
2000: Consigny S; Bentoucha A; Bonnafous P; Grosset J; Ji B
Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.
Antimicrobial agents and chemotherapy 2000;44(10):2919-21.
-
2000: Dega H; Chosidow O; Barete S; Carbonnelle B; Grosset J; Jarlier V
[Mycobacterium ulcerans infection]
Annales de médecine interne 2000;151(5):339-44.
-
2000: Dega H; Robert J; Bonnafous P; Jarlier V; Grosset J
Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.
Antimicrobial agents and chemotherapy 2000;44(9):2367-72.
-
2000: Robert J; Trystram D; Truffot-Pernot C; Carbonnelle B; Grosset J
Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(7):665-72.
-
2000: Robert J; Trystram D; Truffot-Pernot C; Cambau E; Jarlier V; Grosset J
Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(6):504-12.
-
2000: Daniel N; Lounis N; Ji B; O'Brien R J; Vernon A; Geiter L J; Szpytma M; Truffot-Pernot C; Hejblum G; Grosset J
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
American journal of respiratory and critical care medicine 2000;161(5):1572-7.
-
1999: Ji B; Grosset J H
Drugs and regimens for preventive therapy against tuberculosis, disseminated Mycobacterium avium complex infection and leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1999;67(4 Suppl):S45-55.
-
1999: Robert J; Boulahbal F; Trystram D; Truffot-Pernot C; de Benoist A C; Vincent V; Jarlier V; Grosset J
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(8):711-4.
-
1999: Flament-Saillour M; Robert J; Jarlier V; Grosset J
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.
American journal of respiratory and critical care medicine 1999;160(2):587-93.
-
1999: Rinder H; Feldmann K; Tortoli E; Grosset J; Casal M; Richter E; Rifai M; Jarlier V; Vaquero M; Rüsch-Gerdes S; Cambau E; Gutierrez J; Löscher T
Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 1999;4(2):145-52.
-
1999: Grosset J
[Which strategies for eradication of tuberculosis?]
Bulletin de l'Académie nationale de médecine 1999;183(7):25-37; discussion 37-40.
-
1999: Grosset J
[Leprosy and tuberculosis: opposite results?]
Médecine tropicale : revue du Corps de santé colonial 1999;59(2 Suppl):25-30.
-
1998: Grosset J H; Franzblau S
Report of workshop on chemotherapy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1998;66(4):595-6.
-
1998: Carbonne A; Lemaitre N; Bochet M; Truffot-Pernot C; Katlama C; Grosset J; Bricaire F; Jarlier V
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facility.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1998;19(10):784-6.
-
1998: Craft J C; Notario G F; Grosset J H; Heifets L B
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(4):807-12.
-
1998: Jouveshomme S; Cambau E; Trystram D; Szpytma M; Sougakoff W; Derenne J P; Grosset J
Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis.
American journal of respiratory and critical care medicine 1998;158(4):1096-101.
-
1998: Grosset J
[What's new for tuberculosis in 1998?]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1998;19(9):613-6.
-
1998: Schwoebel V; Decludt B; de Benoist A C; Haeghebaert S; Torrea G; Vincent V; Grosset J
Multidrug resistant tuberculosis in France 1992-4: two case-control studies.
BMJ (Clinical research ed.) 1998;317(7159):630-1.
-
1998: Ji B; Lounis N; Maslo C; Truffot-Pernot C; Bonnafous P; Grosset J
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1998;42(8):2066-9.
-
1998: Lemaître N; Sougakoff W; Truffot-Pernot C; Cambau E; Derenne J P; Bricaire F; Grosset J; Jarlier V
Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1998;2(5):390-6.
-
1998: Grosset J; Lounis N; Truffot-Pernot C; O'Brien R J; Raviglione M C; Ji B
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.
American journal of respiratory and critical care medicine 1998;157(5 Pt 1):1436-40.
-
1998: Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Antimicrobial agents and chemotherapy 1998;42(5):1115-20.
-
1998: Grosset J; Truffot-Pernot C
[Mycobacterium xenopi, a newcomer?]
La Revue du praticien 1998;48(7):701-3.
-
1997: Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections]
Revue des maladies respiratoires 1997;14 Suppl 5():S33-48.
-
1997: May T; Brel F; Beuscart C; Vincent V; Perronne C; Doco-Lecompte T; Saint-Marc T; Dautzenberg B; Grosset J
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(3):621-9.
-
1997: Ji B; Jamet P; Sow S; Perani E G; Traore I; Grosset J H
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Antimicrobial agents and chemotherapy 1997;41(9):1953-6.
-
1997: Gimenez F; Leblond V; Nguyen J; Serrand P; Binet J L; Grosset J; Thuillier A
Variations of teicoplanin concentrations in neutropenic patients.
Journal of clinical pharmacy and therapeutics 1997;22(3):187-90.
-
1997: Mane I; Cartel J L; Grosset J H
Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1997;65(2):224-9.
-
1997: Lounis N; Ji B; Truffot-Pernot C; Grosset J
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.
Antimicrobial agents and chemotherapy 1997;41(5):1168-9.
-
1997: Grosset J
Whither short-course chemotherapy for leprosy?
Indian journal of leprosy 1997;69(2):119-20.
-
1997: Lounis N; Ji B; Truffot-Pernot C; Grosset J
Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?
Antimicrobial agents and chemotherapy 1997;41(3):607-10.
-
1997: Dautzenberg B; Truffot-Pernot C; Hazebroucq J; Legris S; Guérin C; Begelman C; Guermonprez G; Fievet M H; Chastang C; Grosset J
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections.
Infection 1997;25(1):16-21.
-
1997: Iborra C; Cambau E; Lecomte C; Grosset J; Bricaire F; Caumes E
[Cutaneous tuberculosis. A study of 4 cases]
Annales de dermatologie et de vénéréologie 1997;124(2):139-43.
-
1997: Grosset J; Ji B
Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
Drugs 1997;54 Suppl 2():23-7; discussion 28-9.
-
1996: Lemaître N; Sougakoff W; Coëtmeur D; Vaucel J; Jarlier V; Grosset J
Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(6):531-6.
-
1996: Ji B; Levy L; Grosset J H
Chemotherapy of leprosy: progress since the Orlando Congress, and prospects for the future.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1996;64(4 Suppl):S80-8; discussion S88-90.
-
1996: Ji B; Jamet P; Perani E G; Sow S; Lienhardt C; Petinon C; Grosset J H
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Antimicrobial agents and chemotherapy 1996;40(9):2137-41.
-
1996: Doucet-Populaire F; Lalande V; Carpentier E; Bourgoin A; Dailloux M; Bollet C; Vachée A; Moinard D; Texier-Maugein J; Carbonnelle B; Grosset J
A blind study of the polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA. Azay Mycobacteria Study Group.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(4):358-62.
-
1996: Grosset J
[Bacteriological diagnosis of tuberculosis]
La Revue du praticien 1996;46(11):1337-43.
-
1996: Traore I; Ji B; Lienhardt C; Bobin P; Grosset J
Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1996;64(2):142-5.
-
1996: Lemaitre N; Sougakoff W; Truffot C; Grosset J; Jarlier V
[Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis]
Pathologie-biologie 1996;44(5):452-5.
-
1996: Ji B; Lounis N; Truffot-Pernot C; Grosset J
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
Antimicrobial agents and chemotherapy 1996;40(2):437-42.
-
1996: Ji B; Perani E G; Petinom C; Grosset J H
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Antimicrobial agents and chemotherapy 1996;40(2):393-9.
-
1996: Grosset J
Current problems with tuberculosis treatment.
Research in microbiology 1996;147(1-2):10-6.
-
1995: Chaulet P; Boulahbal F; Grosset J
Surveillance of drug resistance for tuberculosis control: why and how?
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1995;76(6):487-92.
-
1995: Truffot-Pernot C; Lounis N; Grosset J H; Ji B
Clarithromycin is inactive against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1995;39(12):2827-8.
-
1995: Baril L; Caumes E; Truffot-Pernot C; Bricaire F; Grosset J; Gentilini M
Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosa.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):653-5.
-
1995: Enarson D A; Grosset J; Mwinga A; Hershfield E S; O'Brien R; Cole S; Reichman L
The challenge of tuberculosis: statements on global control and prevention.
Lancet 1995;346(8978):809-19.
-
1995: Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
The Journal of antimicrobial chemotherapy 1995;36(1):129-36.
-
1995: JI B; Lounis N; Truffot-Pernot C; Grosset J
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1995;39(6):1341-4.
-
1995: Grosset J; Mouton Y
Is PCR a useful tool for the diagnosis of tuberculosis in 1995?
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1995;76(3):183-4.
-
1995: Struillou L; Cohen Y; Lounis N; Bertrand G; Grosset J; Vildé J L; Pocidalo J J; Perronne C
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice.
Antimicrobial agents and chemotherapy 1995;39(4):878-81.
-
1995: Cohen Y; Perronne C; Lazard T; Truffot-Pernot C; Grosset J; Vilde J L; Pocidalo J J
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity.
Antimicrobial agents and chemotherapy 1995;39(3):735-8.
-
1995: Lounis N; Ji B; Truffot-Pernot C; Grosset J
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.
Antimicrobial agents and chemotherapy 1995;39(3):608-12.
-
1994: Cambau E; Sougakoff W; Besson M; Truffot-Pernot C; Grosset J; Jarlier V
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
The Journal of infectious diseases 1994;170(5):1351.
-
1994: Chapuis L; Ji B; Truffot-Pernot C; O'Brien R J; Raviglione M C; Grosset J H
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.
American journal of respiratory and critical care medicine 1994;150(5 Pt 1):1355-62.
-
1994: Ji B; Lounis N; Truffot-Pernot C; Grosset J
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model.
Antimicrobial agents and chemotherapy 1994;38(11):2521-9.
-
1994: Cambau E; Sougakoff W; Besson M; Truffot-Pernot C; Grosset J; Jarlier V
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
The Journal of infectious diseases 1994;170(2):479-83.
-
1994: Lazard T; Perronne C; Truffot-Pernot C; Grosset J; Vildé J L; Pocidalo J J
Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophages.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(4):283-5.
-
1994: Heym B; Honoré N; Truffot-Pernot C; Banerjee A; Schurra C; Jacobs W R; van Embden J D; Grosset J H; Cole S T
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.
Lancet 1994;344(8918):293-8.
-
1994: Grosset J H
Progress in the chemotherapy of leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1994;62(2):268-77.
-
1994: Grosset J H
Assessment of new therapies for infection due to the Mycobacterium avium complex: appropriate use of in vitro and in vivo testing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18 Suppl 3():S233-6.
-
1994: Ji B; Perani E G; Petinom C; N'Deli L; Grosset J H
Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Antimicrobial agents and chemotherapy 1994;38(4):662-7.
-
1994: Xiong J H; Ji B; Perani E G; Pétinon C; Grosset J H
Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1994;62(1):37-42.
-
1994: Schwoebel V; Hubert B; Grosset J
Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccination.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(1):44-8.
-
1994: Vareldzis B P; Grosset J; de Kantor I; Crofton J; Laszlo A; Felten M; Raviglione M C; Kochi A
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(1):1-7.
-
1993: Ji B; Truffot-Pernot C; Lacroix C; Raviglione M C; O'Brien R J; Olliaro P; Roscigno G; Grosset J
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
The American review of respiratory disease 1993;148(6 Pt 1):1541-6.
-
1993: Honoré N; Perrani E; Telenti A; Grosset J; Cole S T
A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1993;61(4):600-4.
-
1993: Hejblum G; Jarlier V; Grosset J; Aurengo A
Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm.
Journal of clinical microbiology 1993;31(9):2396-401.
-
1993: Lazard T; Perronne C; Grosset J; Vilde J L; Pocidalo J J
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
Antimicrobial agents and chemotherapy 1993;37(8):1690-2.
-
1993: Ji B; Jamet P; Perani E G; Bobin P; Grosset J H
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
The Journal of infectious diseases 1993;168(1):188-90.
-
1993: Glaziou P; Cartel J L; Moulia-Pelat J P; Ngoc L N; Chanteau S; Plichart R; Grosset J H
Tuberculosis in leprosy patients detected between 1902 and 1991 in French Polynesia.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1993;61(2):199-204.
-
1993: Lazard T; Perronne C; Cohen Y; Grosset J; Vilde J L; Pocidalo J J
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.
Antimicrobial agents and chemotherapy 1993;37(4):692-5.
-
1993: Lalande V; Truffot-Pernot C; Paccaly-Moulin A; Grosset J; Ji B
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.
Antimicrobial agents and chemotherapy 1993;37(3):407-13.
-
1993: Dautzenberg B; Saint Marc T; Meyohas M C; Eliaszewitch M; Haniez F; Rogues A M; De Wit S; Cotte L; Chauvin J P; Grosset J
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
Archives of internal medicine 1993;153(3):368-72.
-
1992: Ji B; Lounis N; Truffot-Pernot C; Grosset J
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy.
Antimicrobial agents and chemotherapy 1992;36(12):2839-40.
-
1992: Ji B; Perani E G; Petinon C; Grosset J H
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1992;60(4):556-61.
-
1992: Grosset J H
Treatment of tuberculosis in HIV infection.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1992;73(6):378-83.
-
1992: Perronne C; Cohen Y; Truffot-Pernot C; Grosset J; Vildé J L; Pocidalo J J
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.
Antimicrobial agents and chemotherapy 1992;36(11):2408-12.
-
1992: Rouby J J; Martin De Lassale E; Poete P; Nicolas M H; Bodin L; Jarlier V; Le Charpentier Y; Grosset J; Viars P
Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects.
The American review of respiratory disease 1992;146(4):1059-66.
-
1992: Cohen Y; Perronne C; Truffot-Pernot C; Grosset J; Vilde J L; Pocidalo J J
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages.
Antimicrobial agents and chemotherapy 1992;36(10):2104-7.
-
1992: Cartel J L; Chanteau S; Moulia-Pelat J P; Plichart R; Glaziou P; Boutin J P; Roux J F; Grosset J H
Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1992;60(3):416-20.
-
1992: Cartel J L; Spiegel A; Nguyen Ngoc L; Moulia-Pelat J P; Martin P M; Grosset J H
Leprosy in French Polynesia. The possible impact of multidrug therapy on epidemiological trends.
Leprosy review 1992;63(3):223-30.
-
1992: Cartel J L; Boutin J P; Spiegel A; Glaziou P; Plichart R; Cardines R; Grosset J H
Leprosy in French Polynesia. Epidemiological trends between 1946 and 1987.
Leprosy review 1992;63(3):211-22.
-
1992: Couderc L J; Epardeau B; Dazza M C; Clauvel J P; Autran B; Grosset J; Caubarrere I
Disseminated Mycobacterium avium intracellulare infection without predisposing conditions.
Lancet 1992;340(8821):731.
-
1992: Schwoebel V; Hubert B; Grosset J
Impact of BCG on tuberculous meningitis in France in 1990.
Lancet 1992;340(8819):611.
-
1992: Pretet S; Lebeaut A; Parrot R; Truffot C; Grosset J; Dinh-Xuan A T
Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992;5(6):680-4.
-
1992: Grosset J; Truffot-Pernot C; Lacroix C; Ji B
Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Antimicrobial agents and chemotherapy 1992;36(3):548-51.
-
1991: Dautzenberg B; Truffot C; Legris S; Meyohas M C; Berlie H C; Mercat A; Chevret S; Grosset J
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
The American review of respiratory disease 1991;144(3 Pt 1):564-9.
-
1991: Ji B; Truffot-Pernot C; Grosset J
In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.
Tubercle 1991;72(3):181-6.
-
1991: Dautzenberg B; Truffot C; Mignon A; Rozenbaum W; Katlama C; Perronne C; Parrot R; Grosset J
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
Tubercle 1991;72(3):168-75.
-
1991: Truffot-Pernot C; Ji B; Grosset J
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.
Antimicrobial agents and chemotherapy 1991;35(8):1677-8.
-
1991: Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde J L; Pocidalo J J
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Antimicrobial agents and chemotherapy 1991;35(7):1356-9.
-
1991: Constant-Desportes M; Guelpa-Lauras C C; Carolina J C; Léoture A; Grosset J H; Sansarricq H
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1991;59(2):242-7.
-
1991: Truffot-Pernot C; Ji B; Grosset J
Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments.
Tubercle 1991;72(1):57-64.
-
1991: Ji B; Perani E G; Grosset J H
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Antimicrobial agents and chemotherapy 1991;35(3):579-81.
-
1991: Ji B; Grosset J
Ofloxacin for the treatment of leprosy.
Acta leprologica 1991;7(4):321-6.
-
1990: Chanteau S; Cartel J L; Perani E; N'Deli L; Roux J; Grosset J H
Relationships between PGL-1 antigen in serum, tissue and viability of Mycobacterium leprae as determined by mouse footpad assay in multibacillary patients during short-term clinical trial.
Leprosy review 1990;61(4):330-40.
-
1990: Ji B; Grosset J H
Recent advances in the chemotherapy of leprosy.
Leprosy review 1990;61(4):313-29.
-
1990: Grosset J
[Norfloxacin: a broad-spectrum quinolone for superficial eye infections]
Pathologie-biologie 1990;38(7):735-41.
-
1990: Cartel J L; Chanteau S; Boutin J P; Plichart R; Richez P; Roux J F; Grosset J H
Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1990;58(3):512-7.
-
1990: Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Pocidalo J J; Vilde J L
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
Antimicrobial agents and chemotherapy 1990;34(8):1508-11.
-
1990: Grosset J
Present and new drug regimens in chemotherapy and chemoprophylaxis of tuberculosis.
Bulletin of the International Union against Tuberculosis and Lung Disease 1990;65(2-3):86-91.
-
1990: Grosset J; Boisvert H; Truffot-Pernot C; Rica C
Organization of laboratory services in low prevalence countries, our personal view.
Bulletin of the International Union against Tuberculosis and Lung Disease 1990;65(2-3):60-3.
-
1990: Grosset J H; Ji B H; Guelpa-Lauras C C; Perani E G; N'Deli L N
Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1990;58(2):281-95.
-
1990: Abel L; Cua V V; Oberti J; Lap V D; Due L K; Grosset J; Lagrange P H
Leprosy and BCG in southern Vietnam.
Lancet 1990;335(8704):1536.
-
1990: Grosset J
[Bacteriologic basis for the treatment of tuberculosis]
La Revue du praticien 1990;40(8):715-8.
-
1990: N'Deli L; Guelpa-Lauras C C; Perani E G; Grosset J H
Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1990;58(1):12-8.
-
1990: Grosset J
New experimental regimens for preventive therapy of tuberculosis.
Bulletin of the International Union against Tuberculosis and Lung Disease 1990;66 Suppl():15-6.
-
1989: Cartel J L; Chanteau S; Boutin J P; Taylor R; Plichart R; Roux J; Celerier P; Grosset J H
Implementation of chemoprophylaxis of leprosy in the Southern Marquesas with a single dose of 25 mg per kg rifampin.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1989;57(4):810-6.
-
1989: Lecoeur H F; Truffot-Pernot C; Grosset J H
Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
The American review of respiratory disease 1989;140(5):1189-93.
-
1989: Rouby J J; Rossignon M D; Nicolas M H; Martin de Lassale E; Cristin S; Grosset J; Viars P
A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia.
Anesthesiology 1989;71(5):679-85.
-
1989: Truffot-Pernot C; Lecoeur H F; Maury L; Dautzenberg B; Grosset J
Results of blood cultures for detection of mycobacteria in AIDS patients.
Tubercle 1989;70(3):187-91.
-
1989: Grosset J H; Guelpa-Lauras C C; Bobin P; Brucker G; Cartel J L; Constant-Desportes M; Flageul B; Frédéric M; Guillaume J C; Millan J
Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1989;57(3):607-14.
-
1989: Jarlier V; Nicolas M H; Philippon A; Giroir A M; Grosset J
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
The Journal of antimicrobial chemotherapy 1989;24(2):165-72.
-
1989: Grosset J H; Baohang J; Noordeen S K
Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
Indian journal of leprosy 1989;61(3):323-7.
-
1989: Grosset J H; Ji B H
Controlled clinical trial for evaluation of antimicrobial drug activity against M. leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1989;57(2):529-31.
-
1989: Lecoeur H F; Lagrange P H; Truffot-Pernot C; Gheorghiu M; Grosset J
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
Clinical and experimental immunology 1989;76(3):458-62.
-
1989: Grosset J H
Present status of chemotherapy for tuberculosis.
Reviews of infectious diseases 1989;11 Suppl 2():S347-52.
-
1988: Mitchison D A; Ellard G A; Grosset J
New antibacterial drugs for the treatment of mycobacterial disease in man.
British medical bulletin 1988;44(3):757-74.
-
1988: Grosset J H; Truffot-Pernot C; Lecoeur H
[New and future drugs in pulmonary tuberculosis]
Praxis und Klinik der Pneumologie 1988;42 Suppl 1():206-10.
-
1988: Grosset J H; Guelpa-Lauras C C; Perani E G; Beoletto C
Activity of ofloxacin against Mycobacterium leprae in the mouse.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1988;56(2):259-64.
-
1988: Parrot R G; Grosset J H
Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection.
Tubercle 1988;69(1):47-55.
-
1988: Lepetit C; Thebaud-Mony A; Grosset J
[Tuberculosis in the Department of Seine-Saint Denis. I. Cases under treatment in 1984]
Revue des maladies respiratoires 1988;5(2):129-36.
-
1988: Cartel J L; Boutin J P; Plichart R; Roux J; Grosset J H
[Leprosy in the French Polynesian archipelagoes from 1967 to 1987]
Bulletin de la Société de pathologie exotique et de ses filiales 1988;81(5):819-26.
-
1988: Dautzenberg B; Grosset J
[Tuberculosis and pregnancy]
Revue des maladies respiratoires 1988;5(3):279-83.
-
1988: Truffot-Pernot C; Giroir A M; Maury L; Grosset J
[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare]
Revue des maladies respiratoires 1988;5(4):401-6.
-
1987: Grosset J H; Guelpa-Lauras C C
Activity of rifampin in infections of normal mice with Mycobacterium leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):847-51.
-
1987: Cartel J L; Naudillon Y; Remy J C; Grosset J H
Contribution of relapses to total infection sources of leprosy in Guadeloupe.
Leprosy review 1987;58(4):339-48.
-
1987: McDermott-Lancaster R D; Ito T; Kohsaka K; Guelpa-Lauras C C; Grosset J H
Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):889-95.
-
1987: Grosset J H
Pharmacokinetics in drug screening.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):852-6.
-
1987: Grosset J H; Baohong J; Ito T
The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):807-13.
-
1987: Mouquet C; Fusciardi J; Stoupak M P; Vallancien G; Jarlier V; Chatelain C; Grosset J; Viars P
[Transurethral surgery and persistent urinary infection: effect of a single preoperative dose of cefuroxime]
Pathologie-biologie 1987;35(9):1243-7.
-
1987: Grosset J; Lecoeur H
[Present status of vaccination against leprosy]
Acta leprologica 1987;5(3):231-9.
-
1987: Grosset J; Guelpa-Lauras C C; Millan J; Bodian M; Perani E
[Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)]
Médecine tropicale : revue du Corps de santé colonial 1987;47(2):171-5.
-
1987: Guelpa-Lauras C C; Perani E G; Giroir A M; Grosset J H
Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(1):70-7.
-
1987: Grosset J; Jarlier V; Lecoeur H
[BCG vaccination in France]
Revue des maladies respiratoires 1987;4(2):69-74.
-
1986: Dautzenberg B; Gallinari C; Aeberhardt G; Lévy A; Bernheim J; Grosset J; Sors C
[Routine use of 6-month antitubercular treatment in 300 patients]
Presse médicale (Paris, France : 1983) 1986;15(43):2151-2, 2157-8.
-
1986: Jarlier V; Soussy C J; Chanal M; Sirot D; Le Van Thoi J; Bismuth R; Grosset J; Duval J; Cluzel R
[In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics]
Presse médicale (Paris, France : 1983) 1986;15(46):2272-8.
-
1986: Millan J; Roux G; Loko S; Naudin J C; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
[Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences]
Acta leprologica 1986;4(4):427-44.
-
1986: Cartel J C; Gallais J J; Naudillon Y; Millan J; Grosset J H
[5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980]
Acta leprologica 1986;4(4):415-25.
-
1986: Soga G; Blanc L; Alfa C; Grosset J; Xavier S
[Combined treatments consisting of rifampicin in periodic doses: the experience in Niger]
Acta leprologica 1986;4(4):397-407.
-
1986: Constant-Desportes-Relouzat M; Grosset J; Guelpalauras C C; Salvini B; Cales-Quist D
[Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique]
Acta leprologica 1986;4(3):293-300.
-
1986: Grosset J; Lecoeur H
[Vaccination against leprosy]
Acta leprologica 1986;4(3):289-91.
-
1986: Cartel J L; Gallais J J; Naudillon Y; Rémy J G; Grosset J H
[Epidemiology of leprosy in Guadeloupe from 1970 to 1984]
Acta leprologica 1986;4(2):161-73.
-
1986: Sébille A; Crepon M O; Guelpa C C; Grosset J
[Electrophysiologic demonstration of the activity of rifampicin on nerve disease developing in mice inoculated with Hansen's bacilli in the footpad]
Acta leprologica 1986;4(2):215.
-
1986: Choudat D; Horreard P; Pretet S; Grosset J; Toty L
Superinfection by Aspergillus fumigatus of a pulmonary lesion caused by Mycobacterium xenopi.
Tubercle 1986;67(1):71-4.
-
1986: Millan J; Bodian M; Naudin J C; Diouf B; Boucher P; Ndoye B; Grosset J
[A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used]
Acta leprologica 1986;4(1):19-35.
-
1986: Grosset J H
Recent developments in the field of multidrug therapy and future research in chemotherapy of leprosy.
Leprosy review 1986;57 Suppl 3():223-34.
-
1985: Cartel J L; Gallais J J; Grosset J H
[Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe]
Acta leprologica 1985;3(4):339-55.
-
1985: Sors C; Bouvet E; Grosset J; Perdrizet S; Pretet S
[Aspects of tuberculosis in France]
Revue de l'infirmière 1985;35(15):29-34.
-
1985: Sebille A; Crepon M O; Guelpa C C; Grosset J
Evidence for the activity of rifampin on the neuropathy of foot pad-inoculated mice with Mycobacterium leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1985;53(3):481-3.
-
1985: Nebout M; Grosset J
[Present-day difficulties in the campaign against leprosy and proposals for its resumption in French-speaking Africa]
Acta leprologica 1985;3(3):233-7.
-
1985: Cartel J L; Naudillon Y; Artus J C; Grosset J H
[Epidemiology of leprosy in Guadalupe between 1970 and 1983]
Boletín de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 1985;98(6):535-47.
-
1985: Grosset J
Mechanisms of action of antituberculosis drugs in standard and short-course chemotherapy regimens.
Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia 1985;34(2):108-15.
-
1985: Grosset J
Bacteriological bases of short-course chemotherapy.
Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia 1985;34(2):103-7.
-
1985: Cartel J L; Naudillon Y; Artus J C; Grosset J H
Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1985;53(1):15-8.
-
1985: Grosset J; Levy L; Rees R J; Shepard C C
Drug sensitivity testing of M. leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1985;53(1):118-21.
-
1985: Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse]
Revue des maladies respiratoires 1985;2(4):205-8.
-
1984: Jarlier V; Bismuth R; Nicolas M H; Nguyen J; Truffot C; Grosset J
Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital.
The Journal of antimicrobial chemotherapy 1984;14 Suppl B():59-65.
-
1984: Jarlier V; Truffot-Pernot C; Grosset J
[Potential value of the amoxicillin-clavulanic acid combination in general medicine, gynecology-obstetrics and pediatrics departments]
Pathologie-biologie 1984;32(5 Pt 2):492-5.
-
1984: Guelpa-Lauras C C; Grosset J H; Constant-Desportes M; Brucker G
Nine cases of rifampin-resistant leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1984;52(1):101-2.
-
1984: Dautzenberg B; Grosset J; Fechner J; Lucciani J; Debre P; Herson S; Truffot C; Sors C
The management of thirty immunocompromised patients with tuberculosis.
The American review of respiratory disease 1984;129(3):494-6.
-
1984: Grosset J; Sors C
[Mycobacterioses]
Presse médicale (Paris, France : 1983) 1984;13(4):215-8.
-
1984: Grosset J
[Advances in the chemotherapy of leprosy]
Médecine tropicale : revue du Corps de santé colonial 1984;44(1):17-22.
-
1984: Giroulle H; Bernabeu L; Boisvert H; Truffot C; Grosset J
[Pulmonary mycobacteriosis due to a non-chromogenic, slow-growing, unclassified mycobacterium]
Revue des maladies respiratoires 1984;1(3):161-4.
-
1983: Cartel J L; Millan J; Guelpa-Lauras C C; Grosset J H
Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1983;51(4):461-5.
-
1983: Grosset J; Leventis S
Adverse effects of rifampin.
Reviews of infectious diseases 1983;5 Suppl 3():S440-50.
-
1983: Grosset J; Truffot-Pernot C; Bismuth R; Lecoeur H
[Recent data on the chemotherapy of experimental tuberculosis in the mouse]
Bulletin of the International Union against Tuberculosis 1983;58(2):90-6.
-
1983: Grosset J; Truffot-Pernot C; Lecoeur H; Guelpa-Lauras C C
[Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice]
Pathologie-biologie 1983;31(5):446-50.
-
1983: Bismuth R; Jarlier V; Grosset J
[In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin]
Pathologie-biologie 1983;31(5):429-33.
-
1983: Jarlier V; Bismuth R; Grosset J
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams]
Pathologie-biologie 1983;31(5):336-42.
-
1983: Truffot-Pernot C; Grosset J; Bismuth R; Lecoeur H
[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse]
Revue française des maladies respiratoires 1983;11(6):875-82.
-
1983: Parrot R; Boval C; Grosset J; Gaillard J P
[Adjusting or not adjusting isoniazid dosage?]
Revue française des maladies respiratoires 1983;11(5):705-12.
-
1983: Cooreman J; Burghard G; Grosset J
[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine]
Revue française des maladies respiratoires 1983;11(5):699-704.
-
1982: Grosset J; Truffot-Pernot C
[Laboratories: their role in the diagnosis and treatment of tuberculosis]
Bulletin of the International Union against Tuberculosis 1982;57(3-4):234-41.
-
1982: Grosset J; Truffot C; Fermanian J; Lecoeur H
[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]
Pathologie-biologie 1982;30(6):444-8.
-
1982: Grosset J; Truffot C; Boval C
The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis.
Tubercle 1982;63(1):37-43.
-
1982: Sors C; Dautzenberg B; Grosset J
[Duration of the treatment of tuberculosis in 1981]
La Nouvelle presse médicale 1982;11(11):831.
-
1982: Grosset J; Truffot-Pernot C
[Biology of the tubercle bacillus]
Revue médicale de la Suisse romande 1982;102(3):257-63.
-
1982: Guelpa-Lauras C C; Constant-Desportes M; Millan J; Grosset J
[Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980]
Acta leprologica 1982;(86-87):77-80.
-
1982: Guelpa-Lauras C C; Grosset J; Truffot-Pernot C; Giroir A M
[Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae]
Acta leprologica 1982;(86-87):69-75.
-
1982: Grosset J; Guelpa-Lauras C C; Lecoeur H
[Current data on the bacteriology of leprosy]
Acta leprologica 1982;(86-87):35-45.
-
1982: Grosset J; Bismuth R; Nguyen J
[Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections (author's transl)]
Revue française des maladies respiratoires 1982;10(3):195-203.
-
1982: Nguyen J; Dautzenberg B; Grosset J; Sors C
[Results of antibiotic sensitivity and "Streptococcus pneumoniae" serotype tests in the Pitié-Salpêtrière hospital, France, 1979-1980 (author's transl)]
Revue française des maladies respiratoires 1982;10(2):115-20.
-
1981: Grosset J
Studies in short-course chemotherapy for tuberculosis. Basis for short-course chemotherapy.
Chest 1981;80(6):719-20.
-
1980: Grosset J
Bacteriologic basis of short-course chemotherapy for tuberculosis.
Clinics in chest medicine 1980;1(2):231-41.
-
1980: Grosset J
The efficacy of short-course chemotherapy for tuberculosis.
Bulletin of the Pan American Health Organization 1980;14(2):139-49.
-
1979: Grosset J
[The bacteriological principles of tuberculosis treatments]
La Revue du praticien 1979;29(33):2645-50.
-
1979: Dautzenberg B; Nguyen J; Grosset J; Sors C
[A comparative study of three procedures used for studying bronchopulmonary bacterial flora (author's transl)]
Annales de médecine interne 1979;130(8-9):415-8.
-
1978: Pretet S; Grosset J; Perdrizet S
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]
Bulletin of the International Union against Tuberculosis 1978;53(4):260-1.
-
1978: Grosset J
[Short term chemotherapy of tuberculosis. Current experimental findings in short term chemotherapy]
Bulletin of the International Union against Tuberculosis 1978;53(4):281-3.
-
1978: Grosset J
The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy.
Bulletin of the International Union against Tuberculosis 1978;53(1):5-12.
-
1976: Grosset J; Glaser P; Baud A; Bismuth R
[Bacterial flora in pneumopathies and its significance in surgical resuscitation]
Lille médical : journal de la Faculté de médecine et de pharmacie de l'Université de Lille 1976;21(2):97-9.
-
1973: Vayssairat M; Moulias R; Rameix P; Grosset J; Chomette G; Loeper J
[Two new cases of pulmonary mycobacteriosis due to Mycobacterium xenopi]
Annales de médecine interne 1973;124(4):309-12.
-
1972: Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
[Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970]
Revue de tuberculose et de pneumologie 1972;36(3):337-56.
-
1971: Grosset J
Georges Canetti (1911-1971).
Bulletin of the International Union against Tuberculosis 1971;46():7-8.
-
1971: Grosset J; Decroix G; Sors C
[Tuberculosis due to Mycobacterium africanum in African negroes in the Paris area]
Revue de tuberculose et de pneumologie 1971;35(4):430-6.
-
1971: Boulahbal F; Grosset J
[Use of pyridinium cetyl bromide as a transport medium for tuberculous sputum. Preliminary study]
Archives de l'Institut Pasteur d'Algérie Institut Pasteur d'Algérie 1971;49():51-9.
-
1970: Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Ait-Mesbah H
The efficiency of methods of diagnosing pulmonary tuberculosis: an investigation in a chest clinic in Algiers.
Tubercle 1970;51(4):403-11.
-
1970: Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Zirout A
[Controlled study of a bi-weekly treatment with isoniazid and ethionamide]
Bulletin of the International Union against Tuberculosis 1970;43():282-8.
-
1970: Canetti G; Grosset J; Le Lirzin M
[Sterilization of tuberculous lesions under chemotherapy in humans. Main report]
Bulletin of the International Union against Tuberculosis 1970;43():347-59.
-
1970: Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria]
Revue de tuberculose et de pneumologie 1970;34(4):559-66.
-
1970: de Beco O; Boulahbal F; Grosset J
[Incidence of the bovine bacillus in human tuberculosis at Algiers in 1969]
Archives de l'Institut Pasteur d'Algérie Institut Pasteur d'Algérie 1970;48():93-101.
-
1970: Grosset J; Benhassine M
[Thiacetazone (Tb-1): recent experimental and clinical data]
Bibliotheca tuberculosea 1970;26():107-53.
-
1968: Grosset J; Abderrahim K; Chaulet P; Larbaoui D
[Results of bi-weekly treatment with isoniazid and streptomycine in 135 cases of pulmonary tuberculisis, in Algiers]
Bulletin of the International Union against Tuberculosis 1968;41():325-30.
-
1968: Grosset J; Benhassine M; Mokhtari L
[Trial B.C.G. vaccination without previous tuberculin test in an Algiers outpatient clinic]
Revue de tuberculose et de pneumologie 1968;32(4):551-60.
-
1968: Chaulet P; Boulahbal M; Grosset J
[Acquired resistance to antibiotics of the tuberculosis bacillus in the Algiers area from 1963 to 1967. Importance and epidemiologic significance]
Revue de tuberculose et de pneumologie 1968;32(4):542-51.
-
1968: Seror J; Grosset J
[Apropos of a case of mesenteric adenitis caused by Eberth's bacillus]
Annales de chirurgie 1968;22(9):629-31.
-
1968: Chaulet P; Abderrahim K; Grosset J; Larbaoui D
Clinical experience in Algeria of intermittent treatment of pulmonary tuberculosis with isoniazid and streptomycin twice-weekly.
Tubercle 1968;49():Suppl:81-2.
-
1968: Grosset J; Rodrigues F; Benhassine M; Chaulet P; Larbaoui D
Sensitivity to thiacetazone of strains of Mycobacterium tuberculosis isolated in Algiers: practical deductions.
Tubercle 1968;49():Suppl:46-8.
-
1967: Chaulet P; Larbaoui D; Grosset J; Abderrahim K
Intermittent chemotherapy with isoniazid and streptomycin in Algiers.
Tubercle 1967;48(2):128-36.
-
1967: Grosset J; Benhassine M
[Antibiotic primary resistance of mycobacterium tuberculosis in hospitals in Algeria (1964-1966)]
Revue de tuberculose et de pneumologie 1967;31(4):475-90.
-
1967: Grumbach F; Canetti G; Grosset J; le Lirzin M
Late results of long-term intermittent chemotherapy of advanced, murine tuberculosis: limits of the murine model.
Tubercle 1967;48(1):11-26.
-
1964: CANETTI G; KREIS B; THIBIER R; GROSSET J; GLUSZYK J
[INCIDENCE AND CHARACTERISTICS OF PRIMARY RESISTANCE IN 2144 CASES OF UNTREATED PULMONARY TUBERCULOSIS FROM DIFFERENT REGIONS OF FRANCE. (PRELIMINARY REPORT OF THE CENTRE D'ETUDE SUR LA R'ESISTANCE PRIMAIRE)]
Revue de tuberculose et de pneumologie 1964;28():1115-58.
-
1964: CANETTI G; RIST N; GROSSET J
PRIMARY DRUG RESISTANCE IN TUBERCULOSIS.
The American review of respiratory disease 1964;90():792-9.
-
1964: GRUMBACH F; CANETTI G; GROSSET J
FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES.
Tubercle 1964;45():125-35.
-
1963: VIVIEN J N; THIBIER R; LEPEUPLE A; CANETTI G; GROSSET J
[SYSTEMATIC DETERMINATION OF ACTIVE ISONIAZID IN THE BLOOD SERUM. (DATA FROM A SERIES OF 1,000 PATIENTS)]
Revue de tuberculose et de pneumologie 1963;27():1103-18.
-
1963: CANETTI G; GRUMBACH F; GROSSET J
Long-term, two-stage chemotherapy of advanced experimental murine tuberculosis with intermittent regimes during the second stage.
Tubercle 1963;44():236-40.
-
1963: THIBIER R; LEPEUPLE A; VIVIEN J N; GROSSET J
[RESULTS OF CHEMOTHERAPY AMONG 221 PATIENTS WITH PULMONARY TUBERCULOSIS DUE TO BACILLI INITIALLY SENSITIVE TO PRINCIPAL ANTIBIOTICS (FOLLOW UP OF 2 TO 5 YEARS).]
Revue de tuberculose et de pneumologie 1963;27():541-50.
-
1963: CANETTI G; RIST N; GROSSET J
[Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation.]
Revue de tuberculose et de pneumologie 1963;27():217-72.
-
1963: LEPEUPLE A; THIBIER R; VIVIEN J N; CANETTI G; GROSSET J
[Identification of the sources of contagion in various cases of primary tuberculosis resistance.]
Revue de tuberculose et de pneumologie 1963;27():53-66.
-
1963: CANETTI G; FROMAN S; GROSSET J; HAUDUROY P; LANGEROVA M; MAHLER H T; MEISSNER G; MITCHISON D A; SULA L
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.
Bulletin of the World Health Organization 1963;29():565-78.
-
1962: VIVIEN J N; THIBIER R; LEPEUPLE A; GROSSET J
[The exactness of the practical measurement of active serum isoniazid levels by the vertical diffusion microbiological method.]
Revue de tuberculose et de pneumologie 1962;26():978-88.
-
1962: GROSSET J; CANETTI G
[Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin).]
Annales de l'Institut Pasteur 1962;103():163-84.
-
1962: THIBIER R; CANETTI G; LEPEUPLE A; GROSSET J; VIVIEN J N
[Tuberculosis caused by primary-resistant bacilli in university students during the years 1958-1960.]
Bulletin of the International Union against Tuberculosis 1962;32():113-7.
-
1961: GROSSET J; CANETTI G
[Differences in the number of streptomycin-resistant variants in strains of Mycobacterium tuberculosis according to the type of streptomycin and the culture medium used.]
Annales de l'Institut Pasteur 1961;101():234-52.
-
1961: CANETTI G; GROSSET J
[Percentage of isoniazid-resistant and streptomycin-resistant variants in wild strains of Mycobacterium tuberculosis on Loewenstein-Jensen medium.]
Annales de l'Institut Pasteur 1961;101():28-46.
-
1961: VIVIEN J N; GROSSET J
[The level of active isoniazid in the blood serum.]
Bibliotheca tuberculosea 1961;16():45-121.
-
1960: LEPEUPLE A; THIBIER R; VIVIEN J N; GROSSET J; CANETTI G
[A case of transmission of Koch bacilli from a tuberculous subject to a subject recovered from pulmonary tuberculosis.]
Rivista di chirurgia pediatrica 1960;24():1312-21.
-
1960: CANETTI G; GRUMBACH F; GROSSET J
Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid.
The American review of respiratory disease 1960;82():295-313.
-
1960: THIBIER R; CANETTI G; LEPEUPLE A; GROSSET J; VIVIEN J N
[Pulmonary tuberculosis with resistant bacilli in patients not yet treated.]
Revue de tuberculose et de pneumologie 1960;24():831-68.
-
1960: GRUMBACH F; GROSSET J; CANETTI G
[The inactivation of isoniazid in the rat. Its effects on the results of the chemotherapy of tuberculosis in that species.]
Annales de l'Institut Pasteur 1960;98():642-56.
-
1960: GROSSET J; CANETTI G
[Complementary data on the determination of active isoniazid of the blood serum by the method of vertical diffusion. Determination in presence of PAS.]
Revue de tuberculose et de pneumologie 1960;24():633-47.
-
1958: CANETTI G; BRETEY J; SAENZ A; GROSSET J
[Effect of early treatment with isoniazid on the immunity induced in guinea pigs by a small dose of standard BCG; further data on the immunizing capacity of isoniazid-resistant BCG.]
Annales de l'Institut Pasteur 1958;95(3):262-71.
-
1958: CANETTI G; GROSSET J
[Frequency of post-primary bronchial gland fistulas in 397 cases of pulmonary tuberculosis in adults treated by exeresis; discussion of their phthisiogenic role.]
Revue de la tuberculose 1958;22(7):653-7.
-
1958: VIVIEN J N; THIBIER R; GROSSET J; LEPEUPLE A
[Early results of isoniazid therapy as a function of the active blood level of isoniazid; study of 100 cases.]
Revue de la tuberculose 1958;22(2-3):208-22.
-
1958: GROSSET J; CANETTI G; THIBIER R; VIVIEN J N; LEPEUPLE J; SAENZ A
[Comparative effects of oral and intravenous p-aminosalicylic acid on the active blood level of isoniazid.]
Revue de la tuberculose 1958;22(2-3):202-7.
-
1957: GROSSET J; GRUMBACH F; CANETTI G
[Modification of methods of biological measurement of isoniazid in blood serum; results in 53 cases.]
Annales de l'Institut Pasteur 1957;92(6):752-9.
-
1956: CANETTI G; GROSSET J
[Late positivization of cultures of tuberculosis bacilli; its relation to isoniazid resistance.]
Revue de la tuberculose 1956;20(11-12):1053-61.
Sign-in to see more
